Genetically modified salmon could escape into the wild with devastating consequences for the ecosystem, a new study has warned.

Bexarotene, sold under the name Targretin, had caused ripples of excitement across the medical profession

The US Food and Drug Administration on Wednesday appealed a court order directing the agency to make "morning-after" emergency contraception pills available without a prescription to all girls of reproductive age.

As The Independent reported yesterday, scientists have developed a new method of creating genetically-modified animals that addresses one of the principal objections of the anti-GM movement.

Mandarins in London get an extra hour off each week because of their longer commute

Shares in Reckitt Benckiser took a tumble yesterday on news that its competitors will be able to make heroin-dependency drugs to compete with the consumer goods group.

First patented in 1944 as a nasal decongestant, 1-3 di-methylhexanamine (DMAA) has recently become a popular dietary supplement promoting fat loss and boosting energy.

Scientists have developed a way of modifying a microscopic particle which could offer a new approach to tackling major diseases such as multiple sclerosis, Type 1 diabetes, asthma and food allergies.

MP calls for ban on sale to under-16s after 13 deaths in the US have sparked safety questions

US service members in Afghanistan battle zones who consumed three or more caffeine-charged energy drinks a day were prone to sleepiness and dozing off while on guard duty, according to a report.

An outbreak of a rare form of fungal meningitis is likely to grow after killing four people and sickening 26 in five US states, health officials warned.

Punters in Allergy Therapeutics were breathing a little bit easier yesterday. The Aim-listed drugs company was enjoying a revival after regulators in the States finally decided to rescue its grass pollen allergy vaccine from limbo.

Patients' lives are being put at risk and public money wasted on ineffective medicines because researchers are concealing the results of clinical trials amid a "culture of haphazard publication and incomplete data disclosure".